Home › Database search ›

HSNO application register

The application register is a record of HSNO applications made to the EPA and includes documents related to these applications.

You can search this database by application or approval number.

Please note: The decision documents on this register may not be the current legal approval document for substances included in the application. Substance approvals were reissued on 30 April 2021 to apply the GHS classification system.

Copy and paste the following links to your browser to help you find the correct information:

https://www.epa.govt.nz/assets/Uploads/Documents/Hazardous-Substances/GHS2/Individual-Hazardous-Substance-Approvals.pdf

https://www.epa.govt.nz/assets/Uploads/Documents/Hazardous-Substances/GHS2/GHS_Classifications_and_Fates_30_April_2021.xlsx

You can also search the Approved Hazardous Substances with Controls database and the CCID for information.

Showing 5001 - 5010 of 5408 results for " "

Sort by: Relevance | Date

  • GMD00101

    Decision notified date: 26/07/2000

    To understand transporter proteins in prokaryotes and eukaryotes and develop novel therapies for Helicobacter infection

  • GMD00119

    Decision notified date: 26/07/2000

    The application is made to seek approval to clone and express H. pyloriLpp20 with the sole purpose of using the recombinant protein in the development of an eff…

  • GMD00116

    Decision notified date: 26/07/2000

    The purpose of this application is to generate laboratory strains of the yeast Saccharomyces cerevisiae that can be used to study the function of membrane-bound…

  • GMD00100

    Decision notified date: 26/07/2000

    To study the genes controlling cell growth which may be targets for future drug therapies

  • GMD00114

    Decision notified date: 26/07/2000

    The purpose of this application is to detect potential protein/protein interactions between viral proteins and host proteins in order to further our knowledge o…

  • GMD00102

    Decision notified date: 26/07/2000

    To develop novel therapies for neurological disorders including Parkinson's Disease, epilepsy and injury resulting from stroke

  • GMD00108

    Decision notified date: 26/07/2000

    To study melanocortin receptors and their possible role in Type II diabetes and obesity

  • GMD00097

    Decision notified date: 25/07/2000

    To understand causative role of polymorphisms in the pathogenesis of Type II Diabetes in Maori

  • GMD00096

    Decision notified date: 25/07/2000

    The purpose of this application is to use Escherichia coli expression systems to produce specific streptococcal adhesin polypeptides for research purposes

  • GMD00205

    Decision notified date: 24/07/2000

    To develop a DNA-based test for the mating type which will be used to understand the life cycle of the grapevine pathogen, Eutypa lata. This is an update of GMO…

Print